| Product NDC: | 63874-413 |
| Proprietary Name: | Methylprednisolone |
| Non Proprietary Name: | methylprednisolone |
| Active Ingredient(s): | 4 mg/1 & nbsp; methylprednisolone |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 63874-413 |
| Labeler Name: | Altura Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA011757 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100101 |
| Package NDC: | 63874-413-21 |
| Package Description: | 21 TABLET in 1 BOTTLE, PLASTIC (63874-413-21) |
| NDC Code | 63874-413-21 |
| Proprietary Name | Methylprednisolone |
| Package Description | 21 TABLET in 1 BOTTLE, PLASTIC (63874-413-21) |
| Product NDC | 63874-413 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | methylprednisolone |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20100101 |
| Marketing Category Name | NDA |
| Labeler Name | Altura Pharmaceuticals, Inc. |
| Substance Name | METHYLPREDNISOLONE |
| Strength Number | 4 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |